These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 15339679)
1. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679 [TBL] [Abstract][Full Text] [Related]
2. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195 [TBL] [Abstract][Full Text] [Related]
3. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783 [TBL] [Abstract][Full Text] [Related]
4. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining. Schmidt U; Herbst J; Metz KA; Leder LD J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204 [TBL] [Abstract][Full Text] [Related]
5. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Kamel OW; Gelb AB; Shibuya RB; Warnke RA Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553 [TBL] [Abstract][Full Text] [Related]
6. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Rüdiger T; Jaffe ES; Delsol G; deWolf-Peeters C; Gascoyne RD; Georgii A; Harris NL; Kadin ME; MacLennan KA; Poppema S; Stein H; Weiss LE; Müller-Hermelink HK Ann Oncol; 1998; 9 Suppl 5():S31-8. PubMed ID: 9926235 [TBL] [Abstract][Full Text] [Related]
7. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease. De Jong D; Van Gorp J; Sie-Go D; Van Heerde P Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116 [TBL] [Abstract][Full Text] [Related]
8. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap. Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472 [TBL] [Abstract][Full Text] [Related]
9. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease. Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355 [TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study. Nguyen DT; Diamond LW; Hansmann ML; Fischer R Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732 [TBL] [Abstract][Full Text] [Related]
11. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays. McCune RC; Syrbu SI; Vasef MA Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862 [TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry. Rüdiger T; Ott G; Ott MM; Müller-Deubert SM; Müller-Hermelink HK Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980 [TBL] [Abstract][Full Text] [Related]
13. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma]. Kovrigina AM; Probatova NA Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291 [TBL] [Abstract][Full Text] [Related]
14. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma. Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176 [TBL] [Abstract][Full Text] [Related]
15. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Torlakovic E; Tierens A; Dang HD; Delabie J Am J Pathol; 2001 Nov; 159(5):1807-14. PubMed ID: 11696441 [TBL] [Abstract][Full Text] [Related]
17. The distinction of Hodgkin's disease from B cell lymphoma. Warnke RA Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850 [TBL] [Abstract][Full Text] [Related]
18. Histopathology of Hodgkin's lymphoma. Eberle FC; Mani H; Jaffe ES Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308 [TBL] [Abstract][Full Text] [Related]
19. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities? Schmidt U; Metz KA; Leder LD Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762 [TBL] [Abstract][Full Text] [Related]